z-logo
Premium
Congress President's Welcome
Author(s) -
Fan, ST,
Yang, Z,
Tam, KH,
Ho, DWY,
Poon, RTP,
Lau, CK,
Ngai, PP,
Lam, CT
Publication year - 2006
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2006.01442a.x
Subject(s) - medicine
Background: A transit increase of plasma IL-10 level was detected duringthe early phase after reperfusion in the patients with liver transplantation.However, the possible mechanism that regulates this transit upregulationof endogenous IL-10 and its potential role in ischemia/reperfusion injuryand immune response remains to be determined. Aim of Study: We aimedto explore the potential role of the transit upregulation of endogenous IL-10 in ischemia/reperfusion injury and long-term survival of liver grafts ina rat orthotopic liver transplantation model. Materials and Methods:Male DA (RT1a) and LEW (RT1l) rats were used as donors and recipients,respectively. Experimental groups included: 1) No treatment (isograft); 2)IL-10 neutralizing antibody (isograft); 3) No treatment (allograft); 4) IL-10 Ab (allograft); 5) FK506 1 mg/kg intramuscular injection (im), Days 0-7 (allograft); 6) FK506, Days 2-7 (allograft); 7) IL-10 Ab combined withFK506, Days 2-7 (allograft); 8) Low dose FK506 (0.1 mg/kg); 9) Low doseFK506 combined with IL-10 recombinant protein (allograft). Plasma levelsof IL-10 were detected by ELISA. Primary culture of tissue lymphocyteswas performed. Foxp3 mRNA and protein expression was determined.Flow cytometry was performed to detect IL-10 expression in tissuemacrophages. Results: Long-term survival was observed in isografts,allografts with FK506 treatment and with low dose FK506 combined withIL-10 protein. However, administration of IL-10 neutralizing antibodysignificantly reduced the long-term survival of isografts, and allograftswith FK506 treatment. Decreased plasma levels of IL-10 were found in thegroups receiving IL-10 Ab and FK506 treatment. Parallel to the destructionof liver graft histology, increased plasma levels of ALT and total bilirubinwere detected in the groups with the treatment of IL-10 Ab during the earlyphase after reperfusion. Administration of IL-10 Ab reduced the expressionof IL-10 in tissue macrophages, and at the same time, downregulated theexpression of Foxp3 in the primarily isolated lymphocytes. Conclusions:The transit upregulation of endogenous IL-10 in liver grafts played animportant role in prevention of ischemia/reperfusion injury and inductionof long-term allograft survival, probably through generation of T regulatorycells.link_to_subscribed_fulltex

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom